Skip to library content
Back to the shelf
Peptide library
In clinical trialsImmune & defense

Aviptadil

Also called VIP, RLF-100

Evidence
Limited research
Class
Vasoactive intestinal peptide

Aviptadil belongs to the Vasoactive intestinal peptide class. This library groups it under immune & defense. Its source category is In clinical trials.

Research libraryPeppy Care
Source snapshot
References11 linked sources

At a glance

Aviptadil research overview
Compound classVasoactive intestinal peptide
Associated brandsZyesami
Body systemImmune & defense
Use or research focusARDS; respiratory failure
Regulatory statusInvestigational
Source evidence ratingLimited research

How does Aviptadil work?

VPAC receptor agonism; anti-inflammatory in lung.

The source catalog maps this mechanism to Lung / Respiratory. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.

What does the evidence tell us?

The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.

Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.

Safety and considerations

A compound being studied in a clinical trial is not necessarily approved or effective. Trial participants follow a study protocol with eligibility criteria and monitoring. Results from one population or formulation may not apply to another.

This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.

Common questions

What is Aviptadil?

Aviptadil belongs to the Vasoactive intestinal peptide class. This library groups it under immune & defense. Its source category is In clinical trials. Its recorded use or research focus is: ARDS; respiratory failure.

Is Aviptadil FDA-approved?

The catalog records: Investigational. Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.

How strong is the research?

The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.

Where can I read the research?

The Citations tab contains 11 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.

More for immune & defense

Factual catalog fields and citation links are adapted from Superpower’s Aviptadil guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.